Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease rheumatoid arthritis
Symptom C0007222|cardiovascular disease
Sentences 61
PubMedID- 21846359 Ccr5delta32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study.
PubMedID- 25011482 Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 22808986 Different techniques have proven to be useful in determining the presence of subclinical cardiovascular disease in patients with rheumatoid arthritis (ra).
PubMedID- 23256829 The risk of cardiovascular disease associated with rheumatoid arthritis equals that of diabetes mellitus.
PubMedID- 22360682 Lack of association between tlr4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 21345288 Lack of association between retn rs1862513 polymorphism and cardiovascular disease in rheumatoid arthritis patients.
PubMedID- 23848174 cardiovascular diseases in patients with rheumatoid arthritis: comment on the article by koivuniemi et al.
PubMedID- 22272574 Influence of mhciita rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis.
PubMedID- 25754335 rheumatoid arthritis (ra) associates with increased cardiovascular disease (cvd) mortality thought to be due to accelerated arterial disease.
PubMedID- 22249350 Risk factors for cardiovascular disease in rheumatoid arthritis.
PubMedID- 22657383 Association of the methionine sulfoxide reductase a rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 23584985 Novel risk factors for cardiovascular disease in rheumatoid arthritis.
PubMedID- 24511540 Suggests that vegfa polymorphisms do not seem to exert a significant influence on the risk of cardiovascular disease in patients with rheumatoid arthritis 6.
PubMedID- 23079082 Introduction: recent studies revealed that co-morbidity and mortality due to cardiovascular disease are increased in patients with rheumatoid arthritis (ra) but little is known about factors involved in these manifestations.
PubMedID- 21388351 Vascular endothelial growth factor a and cardiovascular disease in rheumatoid arthritis patients.
PubMedID- 24585741 Objective: despite numerous studies reporting increased cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra), the impact of ra on managing modifiable cvd risk factors remains understudied.
PubMedID- 22927710 Genetic markers of cardiovascular disease in rheumatoid arthritis.
PubMedID- 21981268 Lack of association of il6r rs2228145 and il6st/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 24498229 Conclusion: in observational studies the finding of incident cardiovascular disease in patients with rheumatoid arthritis exposed to glucocorticoids is strongly confounded by indication due to high disease activity.
PubMedID- 24268008 cardiovascular disease in rheumatoid arthritis.
PubMedID- 22337246 Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 22337612 Apolipoprotein b-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 20842919 cardiovascular diseases in rheumatoid arthritis.
PubMedID- 22513132 The excess risk of cardiovascular disease (cvd) associated with rheumatoid arthritis (ra) has long been recognized .
PubMedID- 21411091 Prediction of genetic risk for cardiovascular disease in patients with rheumatoid arthritis: present and promises.
PubMedID- 20638217 Objective: this paper describes the rationale and design of a theory-informed patient education programme addressing cardiovascular disease for people with rheumatoid arthritis (ra) to illustrate how theory can explicitly be translated into practice.
PubMedID- 20383550 Atherosclerosis plays a key role in cardiovascular disease in patients with rheumatoid arthritis (ra).
PubMedID- 20868308 Objectives: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd).
PubMedID- 23666917 Objective: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd), but little is known about its association with another form of vascular disorder, venous thromboembolism (vte).
PubMedID- 20735865 Palomino-morales and colleagues 1 report the novel observation that a common polymorphism in the gene for methylene tetrahydrofolate reductase (mthfr) that markedly reduces enzyme activity (by as much as 65% in homozygotes) may predispose to the development of atherosclerotic cardiovascular disease (ascvd) in patients with rheumatoid arthritis (ra).
PubMedID- 21071477 Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.
PubMedID- 21073447 To assess the potential association between adipoq rs266729 and rs1501299 gene polymorphisms, either isolated or in combination, and cardiovascular disease in patients with rheumatoid arthritis (ra), 674 patients seen at the rheumatology outpatient clinics of hospital xeral-calde, lugo, and hospital san carlos, madrid, spain, were analyzed.
PubMedID- 23193471 cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america.
PubMedID- 21520672 Excess mortality from cardiovascular disease in patients with rheumatoid arthritis--nsaid a possible cause.
PubMedID- 23749610 Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study.
PubMedID- 23244227 Objectives: to study cardiovascular autopsy findings and the lifetime prevalence of cardiovascular diseases (cvds) in patients with rheumatoid arthritis (ra).
PubMedID- 24874661 Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis.
PubMedID- 21420089 Tnfa -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 20827876 cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions.
PubMedID- 21276397 Excess mortality from cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 23983474 The effects of the il-6r and il-6st/gp130 genes on the risk for cardiovascular disease in patients with rheumatoid arthritis were assessed in patients with rheumatoid arthritis who were genotyped for the functional gene polymorphisms.
PubMedID- 22284683 We also suggest strategies for risk stratification and treatment of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 20040642 Risk factors for cardiovascular disease in rheumatoid arthritis: defining treatment thresholds.
PubMedID- 21385539 Lack of association between lep rs2167270 (19 g>a) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 24458537 The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients.
PubMedID- 21269581 Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 21180241 Platelet histogram indices and cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 20164773 cardiovascular disease in rheumatoid arthritis: a step forward.
PubMedID- 23899926 Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 22935383 Objectives: the impact of metabolic risk factors on atherosclerotic cardiovascular disease (acvd) in patients with rheumatoid arthritis (ra) from developing populations is currently unknown.

Page: 1 2